Perimyocarditis in Adolescents After Pfizer-BioNTech COVID-19 Vaccine
- PMID: 34319393
- PMCID: PMC8344528
- DOI: 10.1093/jpids/piab060
Perimyocarditis in Adolescents After Pfizer-BioNTech COVID-19 Vaccine
Abstract
On May 10, 2021, the Emergency Use Authorization of the Pfizer-BioNTech COVID-19 Vaccine (BNT162b2) was expanded to include adolescents (May 10, 2021. https://www.fda.gov/news-events/press-announcements/coronavirus-covid-19-update-fda-authorizes-pfizer-biontech-covid-19-vaccine-emergency-use). We describe clinical characteristics of 8 adolescents who presented over the course of 36 days to Nicklaus Children's Hospital with perimyocarditis within 4 days of receiving a dose of BNT162b2 vaccine.
Keywords: BNT162b2; COVID-19 vaccine; myocarditis; pericarditis.
© The Author(s) 2021. Published by Oxford University Press on behalf of The Journal of the Pediatric Infectious Diseases Society. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.
Figures
References
-
- Canter CE, Simpson KE, Simpson KP. Diagnosis and treatment of myocarditis in children in the current era. Circulation 2014; 129:115–28. - PubMed
-
- Manda YR. Myopericarditis. StatPearls [Internet]. 2020. https://www.ncbi.nlm.nih.gov/books/NBK534776/
-
- Halsell JS, Riddle JR, Atwood JE, et al. ; Department of Defense Smallpox Vaccination Clinical Evaluation Team . Myopericarditis following smallpox vaccination among vaccinia-naive US military personnel. JAMA 2003; 289:3283–9. - PubMed
-
- Su JR, McNeil MM, Welsh KJ, et al. Myopericarditis after vaccination, Vaccine Adverse Event Reporting System (VAERS), 1990-2018. Vaccine 2021; 39:839–45. - PubMed
-
- Marshall M, Ferguson I, Lewis P, et al. Symptomatic acute myocarditis in seven adolescents following Pfizer-BioNTech COVID-19 vaccination. Pediatrics 2021:148:e2021052478. - PubMed
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
